Sana Biotechnology Income Statement (2020-2026) | SANA

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
45.00M53.24M108.50M72.69M72.54M76.73M63.92M67.17M73.04M65.61M7.00M56.45M60.87M53.21M1.90M37.19M29.76M30.11M34.92M28.72M
Selling, General & Administrative (Quarter)
12.48M13.43M12.68M14.43M18.29M15.51M23.32M16.77M16.57M19.18M20.78M16.27M16.44M14.05M17.28M11.48M10.34M10.29M12.19M11.46M
Other Operating Expenses (Quarter)
16.75M-9.90M-55.44M-17.93M-6.06M-249.44M0.12M26.68M-82.61M-209.99M-68.66M-72.02M-64.27M-16.57M1.96M-37.86M-38.34M-44.33M8.43M
Operating Expenses (Quarter)
57.47M83.43M111.28M31.68M72.90M86.19M-162.20M84.05M116.29M2.18M-182.21M4.06M5.29M2.99M2.60M50.63M2.24M2.05M2.78M48.61M
Operating Income (Quarter)
18.55M-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M
EBIT (Quarter)
18.55M-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M
Non-operating items
Interest & Investment Income (Quarter)
-0.04M-0.10M-1.28M-3.81M-1.18M-0.07M2.09M2.19M1.27M0.66M0.14M0.04M-0.00M0.07M-0.04M-0.01M0.02M0.01M-0.03M
Other Non Operating Income (Quarter)
0.00M0.01M0.28M-0.10M-0.20M-0.11M-0.27M-0.05M-0.08M0.30M-0.22M0.21M-4.12M-0.74M0.14M0.25M0.60M0.36M1.10M0.45M
Non Operating Income (Quarter)
0.13M0.16M0.27M0.34M0.64M1.17M1.61M1.98M2.37M2.86M2.73M3.03M3.20M2.58M1.66M0.99M0.58M1.00M1.28M0.95M
Net income details
EBT (Quarter)
-16.36M-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M
Profit After Tax (Quarter)
18.68M-83.26M-110.62M-31.45M-72.47M-85.12M-83.40M-82.12M-114.00M1.65M-88.12M-107.47M-50.29M-59.92M-49.07M-49.40M-93.80M-42.15M-58.83M-47.24M
Income from Continuing Operations (Quarter)
-16.36M-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M
Consolidated Net Income (Quarter)
-16.36M-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M
Income towards Parent Company (Quarter)
-16.36M-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M
Net Income towards Common Stockholders (Quarter)
-16.36M-254.38M-269.19M-215.55M-142.88M-85.12M-83.41M-188.49M-351.07M0.98M-493.14M-196.66M-132.38M-59.92M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M
Additional items
EPS (Basic) (Quarter)
-0.09-1.40-1.62-1.16-0.76-0.45-0.44-0.99-1.820.00-2.53-0.91-0.56-0.25-0.23-0.91-0.94-0.33-0.24-0.59
EPS (Diluted) (Quarter)
-0.09-1.40-1.62-1.16-0.76-0.45-0.44-0.99-1.820.00-2.53-0.91-0.56-0.25-0.23-0.91-0.94-0.33-0.24-0.59
Shares Outstanding (Quarter)
179.90M181.83M166.43M185.96M187.63M189.30M188.34M191.23M192.54M196.98M194.54M217.29M234.44M235.41M230.89M237.58M238.41M260.49M253.23M276.86M
Shares Outstanding (Diluted) (Quarter)
190.51M181.83M166.43M185.96M187.63M189.30M188.34M191.23M192.54M200.47M194.54M217.29M234.44M235.41M230.89M237.58M238.41M260.49M253.23M276.86M
EBITDA (Quarter)
18.55M-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M
Interest Expenses (Quarter)
34.87M170.86M156.62M180.06M68.80M154.76M3.71M106.62M236.06M207.55M402.66M85.98M83.00M176.43M1.48M166.39M130.28M42.59M0.00M113.77M